New research suggests that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt conventional lifestyle programs.
Published data in a leading health publication shows that while overweight individuals often shed about a fifth of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying such treatments must be cognizant of the potential of rapid weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
That rate of recovery means a return to original mass within about one and a half years.
Analyzing Therapies
The study, which reviewed dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with conventional dieting.
The team point out that individuals who shed pounds through dieting generally experience a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Rebound
Doctors suggest the mode of action of the injections explains the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' results in appetite is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Health authorities advise the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, considering the high risk of relapse, the treatment might need to be long-term.
This opinion is supported by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," similar to managing conditions like hypertension.
User Testimonies
Users who have stopped the jabs describe a intense return of appetite.
"I experienced a trigger that goes on and I was suddenly extremely hungry," said an individual.
This challenge is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.
Significant Interest
Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.
- Use is more common among females than males.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success relies on combined lifestyle support.
